Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
8.18
+0.22 (2.76%)
At close: Nov 6, 2026, 4:00 PM EST
8.19
+0.01 (0.12%)
After-hours: Nov 6, 2026, 7:30 PM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.94B in the quarter ending September 30, 2026, with 9.70% growth. This brings the company's total for the last twelve months to $13.22B, up 11.34% year-over-year. In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth. That makes Bausch Health Companies the 1,361st largest company in the world by revenue and 428th in the United States.
Revenue (ttm)
$13.22B
Revenue Growth
+11.34%
P/S Ratio
0.28
Revenue / Employee
$547,438
Employees
20,300
Market Cap
3.06B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Bausch Health Companies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | 1.45B | 21.75% |
| Dec 31, 2021 | 6.67B | -1.35B | -16.87% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.09B |
| Supernus Pharmaceuticals | 1.37B |
| Trulieve Cannabis | 1.14B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 961.51M |
| HUTCHMED (China) | 549.12M |
| Alvotech | 494.61M |
| Liquidia | 450.91M |
BHC News
- 1 day ago - Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026 - PRNewsWire
- 9 days ago - Bausch Health price target raised to $8 from $6.50 at Jefferies - TheFly
- 10 days ago - Bausch Health Companies Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - Bausch Health Companies Earnings release: Q3 2026 - Filings
- 10 days ago - Bausch Health Companies Slides: Q3 2026 - Filings
- 10 days ago - Bausch Health Companies Quarterly report: Q3 2026 - Filings
- 10 days ago - Bausch Health reports Q3 adjusted EPS $1.77, consensus $1.24 - TheFly
- 10 days ago - Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027 - PRNewsWire